
Triglimifon LS 2 Tablet SR
Marketer
Foncer Pharma Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Triglimifon LS 2 Tablet SR
Diabetic patients benefit from Glycemia Control Duo SR tablets, a dual-action formulation designed to manage blood glucose. This medication, used alongside a balanced diet and regular exercise, enhances blood sugar regulation in adult type 2 diabetics. It facilitates improved insulin efficiency, consequently reducing blood glucose. Glycemia Control Duo SR should be administered precisely as prescribed by your physician, adhering strictly to the recommended dosage and timeframe. Ingestion with food is advised to minimize gastrointestinal discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose, in which case the missed dose should be omitted. Never double the dose; overdose may result in dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals can precipitate hypoglycemia; therefore, regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions. Pregnant or lactating individuals must also seek medical counsel before use. Kidney function tests will be conducted prior to treatment initiation. Excessive alcohol should be avoided as it can heighten the risk of adverse reactions.
Primary Ingredients of Triglimifon LS 2 Tablet SR
No text provided to rephrase.
Uses of Triglimifon LS 2 Tablet SR
Managing type 2 diabetes
Major Benefits of Triglimifon LS 2 Tablet SR:
Consume Triglimifon LS 2 Tablet SR precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with food.
Common Side effects of Triglimifon LS 2 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimifon LS 2 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Triglimifon LS 2 Tablet SR should be administered with a meal.
How Triglimifon LS 2 Tablet SR works:
Triglimifon LS 2 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triglimifon LS 2 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimifon LS 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. Your physician will assess the potential benefits against these risks prior to any prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Triglimifon LS 2 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Triglimifon LS 2 Tablet SR, as dose modification may be necessary. Individuals with severe kidney disease should avoid this medication. Close monitoring of kidney function is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Triglimifon LS 2 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Triglimifon LS 2 Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Triglimifon LS 2 Tablet SR :
Should you forget a Triglimifon LS 2 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Triglimifon LS 2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
